Abliva AB clinical trials
Acquired by Pharming Group N.V., Feb 7, 2025 · source ↗
The registry lists 2 studies whose lead sponsor is Abliva AB. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2021.
Before and after it joined Pharming Group N.V.
- First submitted before Abliva AB became part of Pharming Group N.V.
- 2
- First submitted after Abliva AB became part of Pharming Group N.V.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Abliva AB2 studies
Something wrong with this grouping? Tell us on the Pharming Group N.V. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Pharming Group N.V. studies →
- A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial DiseaseCompletedNCT03888716Phase 1
Sponsor listed in the registry: Abliva AB · First submitted before Abliva AB became part of Pharming Group N.V.
- Drug-drug Interaction Study of KL1333 in Healthy SubjectsCompletedNCT04643249Phase 1
Sponsor listed in the registry: Abliva AB · First submitted before Abliva AB became part of Pharming Group N.V.